Cleargreens Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 05-12-2024
- Paid Up Capital ₹ 1.00 M
as on 05-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 05-12-2024
- Revenue 10.49%
(FY 2022)
- Profit 3.35%
(FY 2022)
- Ebitda 4.72%
(FY 2022)
- Net Worth 32.75%
(FY 2022)
- Total Assets 11.45%
(FY 2022)
About Cleargreens Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.00 Cr.
Ramesh Makanbhai, Nisha Navle, and Chetan Majmudar serve as directors at the Company.
- CIN/LLPIN
U24110GJ2017PTC096677
- Company No.
096677
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Cleargreens Pharmaceuticals Private Limited offer?
Cleargreens Pharmaceuticals Private Limited offers a wide range of products and services, including Stock Trading/Money Market, Share Trading Services, Company Law & Labour Law Consultants, Statutory Compliance Services.
Who are the key members and board of directors at Cleargreens Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Makanbhai  | Director | 05-Apr-2017 | Current |
| Nisha Navle | Director | 05-Apr-2017 | Current |
| Chetan Majmudar | Director | 01-Apr-2023 | Current |
Financial Performance of Cleargreens Pharmaceuticals.
Cleargreens Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.49% increase. The company also saw a slight improvement in profitability, with a 3.35% increase in profit. The company's net worth Soared by an impressive increase of 32.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cleargreens Pharmaceuticals?
In 2022, Cleargreens Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Puhas Lifesciences Private LimitedActive 5 years 7 monthsRamesh Makanbhai and Nisha Navle are mutual person
- Puhas Healthcare Private LimitedActive 5 years 1 month
Ramesh Makanbhai and Nisha Navle are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Feb 2023 | ₹4.00 Cr | Open |
How Many Employees Work at Cleargreens Pharmaceuticals?
Unlock and access historical data on people associated with Cleargreens Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cleargreens Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cleargreens Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
